142 related articles for article (PubMed ID: 26436088)
1. MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.
Yan ZX; Zheng Z; Xue W; Zhao MZ; Fei XC; Wu LL; Huang LM; Leboeuf C; Janin A; Wang L; Zhao WL
Biomed Res Int; 2015; 2015():197241. PubMed ID: 26436088
[TBL] [Abstract][Full Text] [Related]
2. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
[TBL] [Abstract][Full Text] [Related]
3. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines.
Sánchez-Hidalgo M; Lee M; de la Lastra CA; Guerrero JM; Packham G
J Pineal Res; 2012 Nov; 53(4):366-73. PubMed ID: 22582944
[TBL] [Abstract][Full Text] [Related]
4. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
[TBL] [Abstract][Full Text] [Related]
7. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
8. Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.
Lei J; Li Q; Gao Y; Zhao L; Liu Y
Sci Rep; 2016 Sep; 6():33717. PubMed ID: 27644318
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
Qian L; Zhang W; Lei B; He A; Ye L; Li X; Dong X
Oncol Rep; 2016 Nov; 36(5):2511-2516. PubMed ID: 27666896
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma.
Yan ZX; Wu LL; Xue K; Zhang QL; Guo Y; Romero M; Leboeuf C; Janin A; Chen SJ; Wang L; Zhao WL
Leukemia; 2014 Apr; 28(4):880-7. PubMed ID: 24104394
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.
Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM
Leukemia; 2012 Nov; 26(11):2336-42. PubMed ID: 22614243
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line.
Lü S; Chen Z; Yang J; Chen L; Gong S; Zhou H; Guo L; Wang J
Exp Hematol; 2008 Oct; 36(10):1278-84. PubMed ID: 18562081
[TBL] [Abstract][Full Text] [Related]
13. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
15. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract][Full Text] [Related]
16. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.
Oliveira LH; Schiavinato JL; Fráguas MS; Lucena-Araujo AR; Haddad R; Araújo AG; Dalmazzo LF; Rego EM; Covas DT; Zago MA; Panepucci RA
Cancer Sci; 2015 Oct; 106(10):1264-77. PubMed ID: 26251039
[TBL] [Abstract][Full Text] [Related]
17. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
Wang J; Liu X; Qiu Y; Shi Y; Cai J; Wang B; Wei X; Ke Q; Sui X; Wang Y; Huang Y; Li H; Wang T; Lin R; Liu Q; Xiang AP
J Hematol Oncol; 2018 Jan; 11(1):11. PubMed ID: 29357914
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling.
Wang L; Chen B; Lin M; Cao Y; Chen Y; Chen X; Liu T; Hu J
Immunobiology; 2015 Mar; 220(3):331-40. PubMed ID: 25457413
[TBL] [Abstract][Full Text] [Related]
19. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
Wang XW; Xu YH
Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
[TBL] [Abstract][Full Text] [Related]
20. TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.
Chu M; Yin K; Dong Y; Wang P; Xue Y; Zhou P; Wang Y; Wang Y
Oncotarget; 2017 Jan; 8(1):1405-1415. PubMed ID: 27902457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]